International Faculty
J. Fernando Arevalo
Edmund F. and Virginia B. Ball Professor of Ophthalmology Chairman, Department of Ophthalmology Johns Hopkins Bayview Medical Center Retina Division, Wilmer Eye Institute The Johns Hopkins University School of Medicine Baltimore, MD, USA
Biography
J. Fernando Arevalo
Edmund F. and Virginia B. Ball Professor of Ophthalmology Chairman, Department of Ophthalmology Johns Hopkins Bayview Medical Center Retina Division, Wilmer Eye Institute The Johns Hopkins University School of Medicine Baltimore, MD, USA
J. Fernando Arevalo, a holder of MD, and PhD degrees, completed his medical and ophthalmology training in Caracas, Venezuela (his native country), before traveling to Bogota, Colombia for a two-year Retina and Vitreous fellowship. After this intensive training, he traveled to the USA for a 2-year Retina and Vitreous/Uveitis and Intraocular Inflammation fellowship at UCSD. The following year, Dr. Arevalo went to Philadelphia for an Ocular Oncology fellowship at Wills Eye Hospital. After a successful academic career in Venezuela for 15 years, Dr. Arevalo was invited by Johns Hopkins University in Baltimore to work as a Professor of Ophthalmology and the Chief of the Retina Division of the King Khaled Eye Hospital (KKESH) in Riyadh, Saudi Arabia for a four-year tenure, followed by an appointment at the Wilmer Eye Institute as the Edmund F. and Virginia B. Ball Professor of Ophthalmology in the Retina Division, and an appointment as chief of ophthalmology at Johns Hopkins Bayview Medical Center in 2015. As a clinical scientist, Dr. Arevalo has more than 900 scientific publications (400 in Pubmed), 18 books, and more than 1300 invited lecture presentations that have led to international recognition and awards. Dr. Arevalo is a former President of the Pan-American Retina and Vitreous Society (2006-2008), Past-President (2017-2019) of the Pan-American Association of Ophthalmology, and current Chairman of the Pan-American Ophthalmological Foundation (2021-24).
Sophie J Bakri
Professor & Chair, Department of Ophthalmology, Mayo Clinic, Rochester MN, USA
Biography
Sophie J Bakri
Professor & Chair, Department of Ophthalmology, Mayo Clinic, Rochester MN, USA
Sophie J. Bakri, MD, MBA is Chair of the Department of Ophthalmology at Mayo Clinic, Rochester, MN and holds the Whitney and Betty MacMillan Professorship in Ophthalmology in Honor of Robert R. Waller, M.D.
Dr. Bakri completed a vitreoretinal surgery fellowship at the Cleveland Clinic Foundation and ophthalmology residency at Albany Medical College, New York. She graduated from the University of Nottingham Medical School, England. She holds an MBA from the Wharton School, University of Pennsylvania. She has authored over 230 peer-reviewed papers and 30 book chapters. She is a principal investigator on numerous multicenter clinical trials on novel drugs for retinal disease. She serves on the Editorial Board of the American Journal of Ophthalmology, Retina, Seminars in Ophthalmology and OSLI Retina. She has served on committees at the Macula Society, Retina Society and AAO, and as a Board Member of the American Society of Retinal Specialists. She currently serves on the Board of Trustees of the American University Professors of Ophthalmology, and of Women in Ophthalmology.
She has received numerous awards, including the Ophthalmologist Top 40 under 40 award, a Senior Achievement Award from the American Academy of Ophthalmology, a Senior Honor Award from the American Society of Retina Specialists and inducted into the Retina Hall of Fame. She has also been honored with receiving the Young Investigator Award from the American Society of Retina Specialists.
Dr. Bakri completed a vitreoretinal surgery fellowship at the Cleveland Clinic Foundation and ophthalmology residency at Albany Medical College, New York. She graduated from the University of Nottingham Medical School, England. She holds an MBA from the Wharton School, University of Pennsylvania. She has authored over 230 peer-reviewed papers and 30 book chapters. She is a principal investigator on numerous multicenter clinical trials on novel drugs for retinal disease. She serves on the Editorial Board of the American Journal of Ophthalmology, Retina, Seminars in Ophthalmology and OSLI Retina. She has served on committees at the Macula Society, Retina Society and AAO, and as a Board Member of the American Society of Retinal Specialists. She currently serves on the Board of Trustees of the American University Professors of Ophthalmology, and of Women in Ophthalmology.
She has received numerous awards, including the Ophthalmologist Top 40 under 40 award, a Senior Achievement Award from the American Academy of Ophthalmology, a Senior Honor Award from the American Society of Retina Specialists and inducted into the Retina Hall of Fame. She has also been honored with receiving the Young Investigator Award from the American Society of Retina Specialists.
David Chow
Toronto Retina Institute / University Toronto, Canada
Biography
David Chow
Toronto Retina Institute / University Toronto, Canada
David Chow works at St Michael's hospital, University of Toronto and is director Toronto Retina Institute. He has published and lectured extensively. His main interests have been in Sugical Instrumentation and technique. He has been on the board of the ASRS, Fellows Forum, co-created CRS, and ha written two textbooks.
Nicole Eter
University of Münster Medical Center, Germany
Biography
Nicole Eter
University of Münster Medical Center, Germany
Professor Nicole Eter completed her specialist training in 1999 and worked as a senior physician in the Department of Ophthalmology at the University Hospital in Bonn. She obtained her habilitation in 2002 and became Professor of Ophthalmology in 2007. In 2010, Professor Eter was appointed Department Chair and Medical Director of the Department of Ophthalmology at the University of Münster. Her core competence lies in vitreoretinal surgery and medical retina, besides covering the entire range of ophthalmic surgical procedures.
She was President of the German Society of Ophthalmology 2017/2018 and is currently Chair of the Association of Ophthalmological Chairholders. She is also part of the EURETINA Board and has been elected incoming president in 2024. Her research focuses on age-related macular degeneration, anti-angiogenic therapies, molecular imaging and nanotechnology in ophthalmology. In 2018, she founded the German Registery for health care research in Ophthalmology (OREGIS). Prof. Eter serves as member of editorial boards and reviewer for several scientific journals, and has written more than 350 articles in peer-reviewed journals and 6 book chapters. She has also given more than 600 scientific presentations.
She was President of the German Society of Ophthalmology 2017/2018 and is currently Chair of the Association of Ophthalmological Chairholders. She is also part of the EURETINA Board and has been elected incoming president in 2024. Her research focuses on age-related macular degeneration, anti-angiogenic therapies, molecular imaging and nanotechnology in ophthalmology. In 2018, she founded the German Registery for health care research in Ophthalmology (OREGIS). Prof. Eter serves as member of editorial boards and reviewer for several scientific journals, and has written more than 350 articles in peer-reviewed journals and 6 book chapters. She has also given more than 600 scientific presentations.
Marta Figueroa
Clinica Baviera, Ramon y Cajal University Hospital, Spain
Biography
Marta Figueroa
Clinica Baviera, Ramon y Cajal University Hospital, Spain
Professor Marta Figueroa is the Medical Director of Clinica Baviera in Madrid. She is also Chief of the Vitreoretinal Department at the Ramon y Cajal University Hospital, Principal Investigator of the Ramon y Cajal Health Research Institute and Professor at the University of Alcalá de Henares.
After studying Medicine at the Complutente University, she completed a residency in ophthalmology at the Ramon y Cajal University Hospital.
Professor Figueroa was the former president of the Retinaplus+ Foundation and the Spanish Vitreoretinal Society. She is currently a member of the Board of the Spanish Vitreoretinal Society and the Spanish Ophthalmological Society.
Professor Figueroa’s main areas of expertise are retinal detachment, diabetic retinopathy, macular surgery, trauma, ARMD, vein occlusions and high myopia. She is the author of more than 180 publications in peer-reviewed journals and text-books. She has given more than 570 conferences on different surgical and medical topics. She serves on several editorial boards in addition to be Associated Editor of the Journal of Vitreoretinal Diseases.
She has received the Achievement Award of the American Academy of Ophthalmology, the Kreissig Award of EURETINA and the Castroviejo Award of the Spanish Society of Ophthalmology.
After studying Medicine at the Complutente University, she completed a residency in ophthalmology at the Ramon y Cajal University Hospital.
Professor Figueroa was the former president of the Retinaplus+ Foundation and the Spanish Vitreoretinal Society. She is currently a member of the Board of the Spanish Vitreoretinal Society and the Spanish Ophthalmological Society.
Professor Figueroa’s main areas of expertise are retinal detachment, diabetic retinopathy, macular surgery, trauma, ARMD, vein occlusions and high myopia. She is the author of more than 180 publications in peer-reviewed journals and text-books. She has given more than 570 conferences on different surgical and medical topics. She serves on several editorial boards in addition to be Associated Editor of the Journal of Vitreoretinal Diseases.
She has received the Achievement Award of the American Academy of Ophthalmology, the Kreissig Award of EURETINA and the Castroviejo Award of the Spanish Society of Ophthalmology.
Kenneth Fong
OasisEye Specialists, Malaysia
Biography
Kenneth Fong
OasisEye Specialists, Malaysia
Dr Fong is a Consultant Ophthalmologist and Vitreoretinal Surgeon and Managing Director of one of the largest private Ophthalmology group practices in Malaysia, OasisEye Specialists. He graduated from the University of Cambridge in 1998 and completed his specialist ophthalmology training in London followed by vitreoretinal surgery fellowships in Cheltenham, UK and Royal Perth Hospital, Australia. He was appointed Associate Professor at the University of Malaya (UM) from 2009-2012 and founded the UM Eye Research Centre .
In 2023, he was voted one of the Top 100 Ophthalmologists in Asia Pacific by the Asia Pacific Journal of Ophthalmology. He is the current Treasurer of the Asia Pacific Academy of Ophthalmologists, Treasurer of the Asia Pacific Vitreoretinal Society and Past President of the Malaysian Society of Ophthalmology. He is a member of the Vision Academy, co-founder of the Subthreshold Ophthalmic Laser Society, and Congress President for the 2023 APAO Congress and 2017 APVRS Congress in Kuala Lumpur.
Dr Fong has published more than 50 scientific papers in international journals as well as book chapters on cataract surgery. He co-authored a book with Ms Goo Chui Hoong, called “Food For Your Eyes” to raise awareness of Age-Related Macular Degeneration (AMD). This book was awarded Best Health Cookbook in the world by the Gourmand Cookbook Awards in Paris in 2013. He has developed innovative new laser techniques for retinal diseases with the industry and is a regular invited speaker and chair at major international conferences.
In 2015, he gave a prestigious TED talk to more than 5000 people in Kuala Lumpur. He is very passionate about prevention of blindness in the community and organized the first ever Malaysia national level “Retinal Disease Awareness Week” in 2013 to raise awareness of AMD and diabetic retinopathy in the public. He is also an examiner for the professional exams of the Royal College of Ophthalmologists (UK).
In 2023, he was voted one of the Top 100 Ophthalmologists in Asia Pacific by the Asia Pacific Journal of Ophthalmology. He is the current Treasurer of the Asia Pacific Academy of Ophthalmologists, Treasurer of the Asia Pacific Vitreoretinal Society and Past President of the Malaysian Society of Ophthalmology. He is a member of the Vision Academy, co-founder of the Subthreshold Ophthalmic Laser Society, and Congress President for the 2023 APAO Congress and 2017 APVRS Congress in Kuala Lumpur.
Dr Fong has published more than 50 scientific papers in international journals as well as book chapters on cataract surgery. He co-authored a book with Ms Goo Chui Hoong, called “Food For Your Eyes” to raise awareness of Age-Related Macular Degeneration (AMD). This book was awarded Best Health Cookbook in the world by the Gourmand Cookbook Awards in Paris in 2013. He has developed innovative new laser techniques for retinal diseases with the industry and is a regular invited speaker and chair at major international conferences.
In 2015, he gave a prestigious TED talk to more than 5000 people in Kuala Lumpur. He is very passionate about prevention of blindness in the community and organized the first ever Malaysia national level “Retinal Disease Awareness Week” in 2013 to raise awareness of AMD and diabetic retinopathy in the public. He is also an examiner for the professional exams of the Royal College of Ophthalmologists (UK).
Ho Xuan Hai
Vietnam National Institute of Ophthalmology, Vietnam Society of Ophthalmology, Vietnam Vitreo- Retinal Society, Viet Nam
Biography
Ho Xuan Hai
Vietnam National Institute of Ophthalmology, Vietnam Society of Ophthalmology, Vietnam Vitreo- Retinal Society, Viet Nam
- Vitreoretinal doctor in Vitreo- Retinal Deparment, Vietnam National Institute of Ophthalmology.
- Graduated the residency and doctoral in Ophthalmology in Hanoi Medical University.
- FFI (Faisant Fonction D'Interne) in France (University of Reims, University Paris Descartes)
- Member of Vietnam Ophthalmology Society, Hanoi Ophthalmology Society, Vietnam Vitreoretinal club.
- Graduated the residency and doctoral in Ophthalmology in Hanoi Medical University.
- FFI (Faisant Fonction D'Interne) in France (University of Reims, University Paris Descartes)
- Member of Vietnam Ophthalmology Society, Hanoi Ophthalmology Society, Vietnam Vitreoretinal club.
J. Michael Jumper
West Coast Retina, USA
Biography
J. Michael Jumper
West Coast Retina, USA
Dr. Jumper is a graduate of the University of Texas Southwestern Medical School in Dallas, Texas. He completed his ophthalmology residency at the University of California, San Francisco and a vitreoretinal fellowship at Duke University. He was retina service chief at Wilford Hall Medical Center in San Antonio, Texas during his service in the United States Air Force. Dr. Jumper is currently the ophthalmology department vice-chairman and vitreoretinal surgery fellowship director at California Pacific Medical Center. He is a member of West Coast Retina Medical Group in San Francisco, California.
Dr. Jumper is a member of the Retina Society, the Association of Pediatric Retinal Surgeons and the American Society of Retina Specialists (ASRS). He served as editor of the annual Preferences and Trends Survey for the ASRS from 2010-2012 and as the editor-in-chief of the Retina Times, journal of the ASRS from 2012-2016. He is currently the president of the ASRS and is a member of the ASRS Executive Committee.
Dr. Jumper has published over 75 journal articles and chapters in the peer-reviewed ophthalmic literature. He has given over 100 presentations and conducted over 25 courses. Dr. Jumper is a scientific reviewer for the American Journal of Ophthalmology, British Journal of Ophthalmology, Ophthalmology, Retina, and Survey of Ophthalmology. He has received the Honor Award from the American Academy of Ophthalmology and the senior Honor Award from the American Society of Retina Specialists. He has twice received the outstanding faculty award in ophthalmology residency training at both the California Pacific Medical Center as well as the University of California, San Francisco.
Dr. Jumper is a member of the Retina Society, the Association of Pediatric Retinal Surgeons and the American Society of Retina Specialists (ASRS). He served as editor of the annual Preferences and Trends Survey for the ASRS from 2010-2012 and as the editor-in-chief of the Retina Times, journal of the ASRS from 2012-2016. He is currently the president of the ASRS and is a member of the ASRS Executive Committee.
Dr. Jumper has published over 75 journal articles and chapters in the peer-reviewed ophthalmic literature. He has given over 100 presentations and conducted over 25 courses. Dr. Jumper is a scientific reviewer for the American Journal of Ophthalmology, British Journal of Ophthalmology, Ophthalmology, Retina, and Survey of Ophthalmology. He has received the Honor Award from the American Academy of Ophthalmology and the senior Honor Award from the American Society of Retina Specialists. He has twice received the outstanding faculty award in ophthalmology residency training at both the California Pacific Medical Center as well as the University of California, San Francisco.
Peter K Kaiser
Cole Eye Institute, USA
Biography
Peter K Kaiser
Cole Eye Institute, USA
Peter K. Kaiser, M.D. graduated magna cum laude with Highest Honors from Harvard College and magna cum laude from Harvard Medical School. He completed an internal medicine internship at Massachusetts General Hospital, an ophthalmology residency at the Massachusetts Eye and Ear Infirmary, and a vitreoretinal fellowship at Bascom Palmer Eye Institute where he was awarded a Heed Ophthalmic Fellowship , before joining the vitreoretinal department of the Cole Eye Institute at the Cleveland Clinic Foundation, Cleveland, Ohio where he is the Chaney Family Endowed Chair in Ophthalmology Research and Professor of Ophthalmology at the Cleveland Clinic Lerner College of Medicine.
As a National Eye Institute and National Institute of Health RO1-funded principal investigator, Dr. Kaiser leads a team involved in the evaluation of vascular biology in age-related macular degeneration (AMD) and diabetic retinopathy (DR). In addition, Dr Kaiser is actively involved in clinical research having served as Study Chairman for numerous major, multi-center, international clinical trials, and principal investigator in over 60 trials evaluating new treatments for AMD, DR, and other retinal disorders. He is the director of Center for Ocular Research and Evaluation (CORE). Dr. Kaiser has been honored to receive the Lew R. Wasserman Award from the Research to Prevent Blindness and the Macula Society’s Young Investigator Award. Complementing his research endeavors, Dr. Kaiser serves on numerous scientific advisory boards and addresses his research interests as an invited speaker at national and international conferences. He is a major contributor to the medical literature having authored 7 textbooks, 30 book chapters, and more than 400 peer-reviewed manuscripts. He served as Editor-in-Chief of Retinal Physician, Associate Editor of International Ophthalmology Clinics, Associate Editor of American Journal of Ophthalmology and serves on the editorial boards of American Journal of Ophthalmology, Retina, Retina Today, and Ocular Surgery News. Dr. Kaiser has been recognized by American Society of Retina Specialists Honor and Senior Honor Awards, along with the American Academy of Ophthalmology Achievement, Senior Achievement, and Lifetime Achievement Awards. He has been listed as one of the “Best Doctors in America” every year since 2002 and named one of the “150 Top Innovators in Retina” by Ocular Surgery News, selected as a charter inductee of the Retina Hall of Fame in 2017, and appeared on the biannual Ophthalmologist’s “Power List” in 2016, 2018, and 2020 as one of the top 100 most influential people in the world of ophthalmology. He is the team ophthalmologist for the Cleveland Cavaliers (National Basketball Association).
As a National Eye Institute and National Institute of Health RO1-funded principal investigator, Dr. Kaiser leads a team involved in the evaluation of vascular biology in age-related macular degeneration (AMD) and diabetic retinopathy (DR). In addition, Dr Kaiser is actively involved in clinical research having served as Study Chairman for numerous major, multi-center, international clinical trials, and principal investigator in over 60 trials evaluating new treatments for AMD, DR, and other retinal disorders. He is the director of Center for Ocular Research and Evaluation (CORE). Dr. Kaiser has been honored to receive the Lew R. Wasserman Award from the Research to Prevent Blindness and the Macula Society’s Young Investigator Award. Complementing his research endeavors, Dr. Kaiser serves on numerous scientific advisory boards and addresses his research interests as an invited speaker at national and international conferences. He is a major contributor to the medical literature having authored 7 textbooks, 30 book chapters, and more than 400 peer-reviewed manuscripts. He served as Editor-in-Chief of Retinal Physician, Associate Editor of International Ophthalmology Clinics, Associate Editor of American Journal of Ophthalmology and serves on the editorial boards of American Journal of Ophthalmology, Retina, Retina Today, and Ocular Surgery News. Dr. Kaiser has been recognized by American Society of Retina Specialists Honor and Senior Honor Awards, along with the American Academy of Ophthalmology Achievement, Senior Achievement, and Lifetime Achievement Awards. He has been listed as one of the “Best Doctors in America” every year since 2002 and named one of the “150 Top Innovators in Retina” by Ocular Surgery News, selected as a charter inductee of the Retina Hall of Fame in 2017, and appeared on the biannual Ophthalmologist’s “Power List” in 2016, 2018, and 2020 as one of the top 100 most influential people in the world of ophthalmology. He is the team ophthalmologist for the Cleveland Cavaliers (National Basketball Association).
Veysel Levent Karabas
Kocaeli University Medical School, Turkiye
Biography
Veysel Levent Karabas
Kocaeli University Medical School, Turkiye
Levent Karabas, MD, FEBO is the Professor of Ophthalmology at the Kocaeli University, Department of Ophthalmology. He is the Director of the Vitreoretinal Service. His clinical practice focuses on vitreoretinal surgery and medical retinal diseases. Levent Karabas graduated from the Istanbul University Faculty of Medicine in 1987, earning a Doctor of Medicine degree. Following graduation, he commenced his residency in Ophthalmology at the Goztepe Training and Research Hospital in Istanbul, where he completed his specialization training.
In 1996, he joined the Department of Ophthalmology at Kocaeli University, where he began his academic and clinical career as a faculty member.
Since 2000, he has been serving as the Head of the Medical Retina and Vitreoretinal Surgery Unit at the Kocaeli University Faculty of Medicine. In this role, he has overseen numerous complex surgical cases, mentored medical students and residents, and has been actively involved in the advancement of vitreoretinal surgical techniques. He is a core team member of the Turkish Vitreo-Retinal Society; they have established clinical, teaching, and research collaborations. He moderated many important congresses and courses of ophthalmology.
Dr. Karabas took part as a principal investigator in many international multicenter clinical trials. He has published more than over 300 articles in domestic and international journals. He has received numerous national and international awards, recognizing his important contributions to ophthalmology through his research, surgical innovations. He is an active member in a number of ophthalmic societies, including the AAO, ASRS, EVRS, Euretina Society, and Turkish Ophthalmological Association.
In 1996, he joined the Department of Ophthalmology at Kocaeli University, where he began his academic and clinical career as a faculty member.
Since 2000, he has been serving as the Head of the Medical Retina and Vitreoretinal Surgery Unit at the Kocaeli University Faculty of Medicine. In this role, he has overseen numerous complex surgical cases, mentored medical students and residents, and has been actively involved in the advancement of vitreoretinal surgical techniques. He is a core team member of the Turkish Vitreo-Retinal Society; they have established clinical, teaching, and research collaborations. He moderated many important congresses and courses of ophthalmology.
Dr. Karabas took part as a principal investigator in many international multicenter clinical trials. He has published more than over 300 articles in domestic and international journals. He has received numerous national and international awards, recognizing his important contributions to ophthalmology through his research, surgical innovations. He is an active member in a number of ophthalmic societies, including the AAO, ASRS, EVRS, Euretina Society, and Turkish Ophthalmological Association.
Anat Loewenstein
Tel Aviv Medical Center, Israel
Biography
Anat Loewenstein
Tel Aviv Medical Center, Israel
Professor and Director, Division of Ophthalmology Tel Aviv Medical Center,
VP Ambulatory Services Tel Aviv Medical Center,
Sidney Fox Chair of Ophthalmology at the Sackler Faculty of Medicine at Tel Aviv University, and President of the Euretina.
Main field of interest is the investigation of drug administration and toxicity to the retina, early detection of macular degeneration and home monitoring of retinal disease.
She has been leading several cutting edge technologies implemented in large scale clinical trials and in clinical setting: the home OCT, a first-of a - kind artificial intelligence-enabled algorithm for monitoring retinal diseases, utilizing an OCT device in the patient's own home, and the development of a technology implementing virtual reality in vitreoretinal surgery in order to replace the standard operating microscope. She also took a pivotal part in the early development of the Port Delivery System - an innovative, FDA approved, intraocular drug delivery system. She serves on advisory boards of most large current pharmaceutical companies.
Published more than 500 papers in peer reviewed journals, and contributed multiple chapters to ophthalmology textbooks.
Serves as the Editor in Chief of the Journal Case Reports in Ophthalmology, is an associate editor of Investigative Ophthalmology & Visual Science Journal, European Journal of Ophthalmology, and of Ophthalmologica.
Has many additional national and international roles as a leader in the field of retinal disease: is a member of the national council of surgery, a member of the Israeli Academy of medicine, is a member in the Academia Ophthalmological Internationalis, leads mentorship groups of ARVO, Euretina and programs sponsored by industry.
Leads multiple mentorship programs to young retina specialists including the Euretina mentorship program and others organized by industry.
Currently serves on the Board of NotalVision and Pulsenmore companies as well as on the board of ESASO (European school for advanced studies in ophthalmology). Serves on multiple advisory boards of most of pharma ophthalmological companies.
VP Ambulatory Services Tel Aviv Medical Center,
Sidney Fox Chair of Ophthalmology at the Sackler Faculty of Medicine at Tel Aviv University, and President of the Euretina.
Main field of interest is the investigation of drug administration and toxicity to the retina, early detection of macular degeneration and home monitoring of retinal disease.
She has been leading several cutting edge technologies implemented in large scale clinical trials and in clinical setting: the home OCT, a first-of a - kind artificial intelligence-enabled algorithm for monitoring retinal diseases, utilizing an OCT device in the patient's own home, and the development of a technology implementing virtual reality in vitreoretinal surgery in order to replace the standard operating microscope. She also took a pivotal part in the early development of the Port Delivery System - an innovative, FDA approved, intraocular drug delivery system. She serves on advisory boards of most large current pharmaceutical companies.
Published more than 500 papers in peer reviewed journals, and contributed multiple chapters to ophthalmology textbooks.
Serves as the Editor in Chief of the Journal Case Reports in Ophthalmology, is an associate editor of Investigative Ophthalmology & Visual Science Journal, European Journal of Ophthalmology, and of Ophthalmologica.
Has many additional national and international roles as a leader in the field of retinal disease: is a member of the national council of surgery, a member of the Israeli Academy of medicine, is a member in the Academia Ophthalmological Internationalis, leads mentorship groups of ARVO, Euretina and programs sponsored by industry.
Leads multiple mentorship programs to young retina specialists including the Euretina mentorship program and others organized by industry.
Currently serves on the Board of NotalVision and Pulsenmore companies as well as on the board of ESASO (European school for advanced studies in ophthalmology). Serves on multiple advisory boards of most of pharma ophthalmological companies.
Hai Lu
Beijing Tongren Hospital, China
Biography
Hai Lu
Beijing Tongren Hospital, China
Chair of Pediatric Retina, Beijing Tongren Hospital, Capital University of Medical Science, Beijing, CHINA
Academy position
Vice-chairman of Chinese Ocular Trauma Society
Editor of 《Chinese Journal of Ophthalmology》《Chinse Journal of Retinal Diseases》
Academy position
Vice-chairman of Chinese Ocular Trauma Society
Editor of 《Chinese Journal of Ophthalmology》《Chinse Journal of Retinal Diseases》
Tamer H Mahmoud
Oakland University William Beaumont School of Medicine, Director, Vitreoretinal Fellowship, Associated Retinal Consultants, Royal Oak, Michigan, USA
Biography
Tamer H Mahmoud
Oakland University William Beaumont School of Medicine, Director, Vitreoretinal Fellowship, Associated Retinal Consultants, Royal Oak, Michigan, USA
Tamer Mahmoud, MD, PhD is a professor of Ophthalmology at Oakland University William Beaumont School of Medicine and the director of the vitreoretinal fellowship at Associated Retinal Consultants. He moved from North Carolina in 2017 where he was the program director of the vitreoretinal surgery fellowship at the Duke University Eye center and a tenured associate professor at Duke. He has developed many surgical techniques including the use of subretinal air to displace submacular hemorrhage and developed and performed the first human autologous retinal transplantation. He also introduced chandelier buckles to the United States and developed the ILM retracting door technique for macular holes. In 2019, he developed the Nanovitreoretinal Surgery Platform. In 2023, he developed the combined amniotic and autologous retinal transplant for refractory macular holes. Dr. Mahmoud initiated global studies for macular holes and currently running the 3rd one focusing on myopic holes.
Dr. Mahmoud graduated Valedictorian from Ainshams University, finished his internship, residency and vitreoretinal fellowship at the Duke University Eye Center. He is a member of the American Academy of Ophthalmology (AAO), the Association of Research in Vision and Ophthalmology (ARVO), the American Society of Retina Specialists, the Club Jules Gonin, the Macula Society, the Retina Society, and the United States Masters Swimming Association. He is a reviewer for many Ophthalmology journals and a principal investigator on many clinical trials sponsored by the industry and the National Eye Institute. He has been invited as a guest speaker all over the world. Dr. Mahmoud is certified by the American Board of Ophthalmology and is licensed in the states of California, Michigan, and North Carolina.
Dr. Mahmoud received the Edward K. Isbey, Jr., M.D. Resident Award for "Excellence in Clinical Care, Ethics, and Research" from the Duke Eye Center, the Retina Research Foundation/"Joseph M. and Eula C. Lawrence" award from ARVO, the "Senior Honor Award" and the “Presidential Honor Award” from the American Society of Retina Specialists, the “Achievement Award” from the AAO, the prestigious Robert A. Machemer research award from the Duke Eye Center, the "Distinguished Teacher of the Year Award" from the Kresge Eye Institute and the “Golden Globe Award” for residents’ education from the Duke Eye Center.
Dr. Mahmoud has been on the list of Best Doctors in America since 2009 and Castle Connolly Top Doctors in Ophthalmology. He was the program director of the Vitreoretinal Surgery Fellowship at the Kresge Eye Institute in Michigan before moving back to Duke in 2011 to join the retina faculty. Wayne State University-Kresge Eye Institute established the "Tamer H. Mahmoud, MD endowed fellowship research award" in 2012. This award is bestowed yearly to the fellow presenting the best paper.
Dr. Mahmoud is a co-founder of the Arab-African Society of Retina Specialists (AASRS), founder of the Duke Surgical Rounds Courses launched at national and international conferences in 2013, and co-founder of the Duke fellows advanced vitreous surgery course (fAVS). He served on the national Therapeutic Safety Committee (TSC) for monitoring of drugs and devices, and founded the North Carolina Retina Club (NCRC) in 2012 to allow interaction and collaboration between retina specialists in the state of North Carolina.
Dr. Mahmoud graduated Valedictorian from Ainshams University, finished his internship, residency and vitreoretinal fellowship at the Duke University Eye Center. He is a member of the American Academy of Ophthalmology (AAO), the Association of Research in Vision and Ophthalmology (ARVO), the American Society of Retina Specialists, the Club Jules Gonin, the Macula Society, the Retina Society, and the United States Masters Swimming Association. He is a reviewer for many Ophthalmology journals and a principal investigator on many clinical trials sponsored by the industry and the National Eye Institute. He has been invited as a guest speaker all over the world. Dr. Mahmoud is certified by the American Board of Ophthalmology and is licensed in the states of California, Michigan, and North Carolina.
Dr. Mahmoud received the Edward K. Isbey, Jr., M.D. Resident Award for "Excellence in Clinical Care, Ethics, and Research" from the Duke Eye Center, the Retina Research Foundation/"Joseph M. and Eula C. Lawrence" award from ARVO, the "Senior Honor Award" and the “Presidential Honor Award” from the American Society of Retina Specialists, the “Achievement Award” from the AAO, the prestigious Robert A. Machemer research award from the Duke Eye Center, the "Distinguished Teacher of the Year Award" from the Kresge Eye Institute and the “Golden Globe Award” for residents’ education from the Duke Eye Center.
Dr. Mahmoud has been on the list of Best Doctors in America since 2009 and Castle Connolly Top Doctors in Ophthalmology. He was the program director of the Vitreoretinal Surgery Fellowship at the Kresge Eye Institute in Michigan before moving back to Duke in 2011 to join the retina faculty. Wayne State University-Kresge Eye Institute established the "Tamer H. Mahmoud, MD endowed fellowship research award" in 2012. This award is bestowed yearly to the fellow presenting the best paper.
Dr. Mahmoud is a co-founder of the Arab-African Society of Retina Specialists (AASRS), founder of the Duke Surgical Rounds Courses launched at national and international conferences in 2013, and co-founder of the Duke fellows advanced vitreous surgery course (fAVS). He served on the national Therapeutic Safety Committee (TSC) for monitoring of drugs and devices, and founded the North Carolina Retina Club (NCRC) in 2012 to allow interaction and collaboration between retina specialists in the state of North Carolina.
Raja Narayanan
Anant Bajaj Retina Institute, LV Prasad Eye Institute, India
Biography
Raja Narayanan
Anant Bajaj Retina Institute, LV Prasad Eye Institute, India
Director, Anant Bajaj Retina Institute, Suven Clinical Research Centre, and Human Resources at LV Prasad Eye Institute; Fellow of ASRS; Member, Macula Society
Kyu-Hyung Park
Seoul National University Hospital,South Korea
Biography
Kyu-Hyung Park
Seoul National University Hospital,South Korea
Dr. Kyu Hyung Park earned his medical degree from the College of Medicine at Seoul National University, Seoul, Korea. He completed his internship and residency in ophthalmology at Seoul National University Hospital. He holds a PhD from Seoul National University and completed a postdoctoral fellowship at Mayo Clinic, USA. He is one of the leading specialists in medical and surgical retina, as well as ocular genetic epidemiology in Korea. He has published over 300 papers in peer-reviewed international journals and serves as principal investigator on numerous clinical trials for age-related macular degeneration, diabetic retinopathy, high myopia, and retinal vein occlusion. He has held prominent roles, including Secretary General of the Korean Ophthalmology Society and the Korean Retina Society. Currently, he serves as the President of the Korean Retina Society and a Director of Ocular Research for the Korean Ophthalmology Society. He is an active member of the Korean Retina Society, Korean Uveitis Society, ARVO, ASRS, the Retina Society, APAO, APVRS, etc.
Currently, he focuses on the medical and surgical management of patients with various retinal diseases, including age-related macular degeneration, diabetic retinopathy, and retinal detachment. He is also engaged in clinical and translational research aimed at developing new diagnostic tools and therapies for angiogenesis-related retinal diseases, including age-related macular degeneration and diabetic retinopathy. He also has been collecting genetic, proteomic, and epidemiologic data on age-related macular degeneration, diabetic retinopathy, and central serous chorioretinopathy, analyzing genetic and proteomic profiles of Koreans to elucidate the genetic markers and potential biomarkers for these diseases.
Jose S Pulido
Larry Donoso Chair of Translational Ophthalmology, Wills Eye Hospital, Philadelphia, PA, USA
Biography
Jose S Pulido
Larry Donoso Chair of Translational Ophthalmology, Wills Eye Hospital, Philadelphia, PA, USA
Jose S. Pulido, MD, MS, MBA, MPH
Larry A. Donoso, MD, PhD, JD, MBA, Endowed Chair
Director of the Henry and Corrine Bower Memorial Laboratories for Translational Medicine
Vickie and Jack Farber Vision Research Center at Wills Eye
Professor, Department of Ophthalmology
Sidney Kimmel Medical College at Thomas Jefferson University
Dr. Pulido is a board-certified ophthalmologist with an extensive research portfolio that has focused on vitreoretinal infectious and inflammatory diseases, retinal degeneration, stem cells, checkpoint inhibitors, and immunotherapies where he has published close to 350 peer-reviewed ophthalmic papers, and numerous books, book chapters, and editorials. Dr. Pulido takes on this new role at Wills Eye as the Director of the Henry and Corrine Bower Memorial Laboratories for Translational Medicine in the Vickie and Jack Farber Vision Research Center at Wills Eye after fifteen years as Professor of Ophthalmology at Mayo Clinic.
Dr. Pulido earned a bachelors and master's in chemistry at the University of Chicago and a degree in medicine from Tulane University School of Medicine. He completed his ophthalmology residency and served as Chief Resident at the University of Illinois at Chicago. Following residency, he completed a vitreoretinal surgery and retina research fellowship at Bascom Palmer Eye Institute at the University of Miami School of Medicine. Additionally, before starting his position at Mayo Clinic, Dr. Pulido earned his MB at the University of Iowa, completed an ocular oncology fellowship at Wills Eye Hospital in Philadelphia and earned an MPH at the University of Illinois at Chicago. Dr. Pulido has held Visiting Professorships and presented named lectures throughout the world. He has more than a dozen patents and won many awards and high honors in the field of ophthalmology throughout his career.
Dr. Pulido’s research interests focuses on translating basic science to the clinical arena and much of his work has centered on vitreoretinal infectious and inflammatory diseases. In more recent work, Dr. Pulido has tried to actually combine his interests in inflammatory diseases and oncology and developed a phase 1 trial using a VSV based vaccine for the treatment of metastatic uveal melanoma. At Wills Eye Hospital, Dr. Pulido will continue to pursue his passion of translational research of inflammatory diseases and immunotherapies to develop innovative clinical therapies for ocular diseases.
Larry A. Donoso, MD, PhD, JD, MBA, Endowed Chair
Director of the Henry and Corrine Bower Memorial Laboratories for Translational Medicine
Vickie and Jack Farber Vision Research Center at Wills Eye
Professor, Department of Ophthalmology
Sidney Kimmel Medical College at Thomas Jefferson University
Dr. Pulido is a board-certified ophthalmologist with an extensive research portfolio that has focused on vitreoretinal infectious and inflammatory diseases, retinal degeneration, stem cells, checkpoint inhibitors, and immunotherapies where he has published close to 350 peer-reviewed ophthalmic papers, and numerous books, book chapters, and editorials. Dr. Pulido takes on this new role at Wills Eye as the Director of the Henry and Corrine Bower Memorial Laboratories for Translational Medicine in the Vickie and Jack Farber Vision Research Center at Wills Eye after fifteen years as Professor of Ophthalmology at Mayo Clinic.
Dr. Pulido earned a bachelors and master's in chemistry at the University of Chicago and a degree in medicine from Tulane University School of Medicine. He completed his ophthalmology residency and served as Chief Resident at the University of Illinois at Chicago. Following residency, he completed a vitreoretinal surgery and retina research fellowship at Bascom Palmer Eye Institute at the University of Miami School of Medicine. Additionally, before starting his position at Mayo Clinic, Dr. Pulido earned his MB at the University of Iowa, completed an ocular oncology fellowship at Wills Eye Hospital in Philadelphia and earned an MPH at the University of Illinois at Chicago. Dr. Pulido has held Visiting Professorships and presented named lectures throughout the world. He has more than a dozen patents and won many awards and high honors in the field of ophthalmology throughout his career.
Dr. Pulido’s research interests focuses on translating basic science to the clinical arena and much of his work has centered on vitreoretinal infectious and inflammatory diseases. In more recent work, Dr. Pulido has tried to actually combine his interests in inflammatory diseases and oncology and developed a phase 1 trial using a VSV based vaccine for the treatment of metastatic uveal melanoma. At Wills Eye Hospital, Dr. Pulido will continue to pursue his passion of translational research of inflammatory diseases and immunotherapies to develop innovative clinical therapies for ocular diseases.
Giuseppe Querques
IRCCS San Raffaele Scintific Insitute, University Vita-Salute San Raffaele, Italy
Biography
Giuseppe Querques
IRCCS San Raffaele Scintific Insitute, University Vita-Salute San Raffaele, Italy
Giuseppe Querques, MD, PhD, is Associate Professor at University Vita-Salute, IRCCS San Raffaele Scientific Institute, Milan, Italy. His main topics are Medical Retina and ophthalmic surgery. Doctor Querques has contributed to more than 600 peer-reviewed articles and over 20 books and book chapters as Editor/Author published mainly in the areas of Medical Retina (age-related macular degeneration, retinal vascular diseases, hereditary retinal diseases, ophthalmic genetics). Doctor Querques is a Board Member of the European Association of Retinal Specialists (EURETINA), and International Retinal Imaging Society (IntRIS), and Member, among others, of the American Academy of Ophthalmology (AAO), the Association for Research in Vision and Ophthalmology (ARVO), the Retina Society, the Club Jules Gonin, and the Macula Society, and is the recipient of the Achievement Award of the AAO and the Young Investigator Award of the Macula Society. Doctor Querques serves as Editor/Associate Editor/Editorial Board Member of Expert Review of Ophthalmology, Nature Scientific Reports, Acta Diabetologica, European Journal of Ophthalmology, Ophthalmologica, Ophthalmology and Therapy, Therapeutic Advances in Ophthalmology, Asia Pacific Journal of Ophthalmology, Retinal Cases & Brief Reports, and American Journal of Ophthalmology Case Reports.
Kourous Rezaei
Illinois Retina Associantes, Rush University Medical Center, USA
Biography
Kourous Rezaei
Illinois Retina Associantes, Rush University Medical Center, USA
Kourous A. Rezaei, M.D., is an internationally recognized expert in the treatment of medical and surgical vitreoretinal diseases. He is associate professor of ophthalmology and director of vitreoretinal fellowship at Rush University Medical Center and is a senior partner at the Illinois Retina Associates in Chicago. Dr. Rezaei is a distinguished inductee of the Retina Hall of Fame and is listed in the Illinois Top Doctors. He is the founder of ChannelR (www.channelr.net) and course director of RETINAWS and Formula Retina. He is a founding member of Retina World Congress, serving on its board as President, is on the board of EURETINA, and is on the organizing committee of the Florence Retina Congress (FLORetina). He had served on the board of the American Society of Retina Specialists (ASRS) and as editorial board member for Investigative Ophthalmology and Visual Science (IOVS), Retina Times (ASRS), Retina Today (BMC), and Eyetube.
Reinier Schlingemann
Amsterdam University Medical Centres, Amsterdam, The Netherlands /Hopital Jules Gonin, Fondation Asile des Aveugles, Switzerland
Biography
Reinier Schlingemann
Amsterdam University Medical Centres, Amsterdam, The Netherlands /Hopital Jules Gonin, Fondation Asile des Aveugles, Switzerland
Professor Reinier Schlingemann is among the foremost researchers in the fields of ocular angiogenesis, blood-retinal barrier and anti-VEGF therapy in the eye. After receiving his medical degree from the University of Leiden Medical School, Leiden, The Netherlands, Professor Schlingemann gained his PhD from the University of Nijmegen in 1990, on the subjects of tumor angiogenesis and tumor vascular targeting.
He undertook his residency in ophthalmology at the University of Amsterdam, The Netherlands, followed by a medical retina fellowship with Professor Alan Bird at Moorfields Eye Hospital, London. He is now Professor of Ophthalmology and Medical Retina Specialist at the Amsterdam UMC in Amsterdam, and Director of Research and Invited Professor at the Jules-Gonin Eye Hospital, University of Lausanne .
Professor Schlingemann’s research interests include: the role of growth factors in ocular angiogenesis and fibrosis-particularly in AMD and diabetic retinopathy; the cellular mechanisms underlying loss of the blood-retinal barrier in diabetic retinopathy; vaso-occlusive mechanisms that cause non-perfusion of the retinal vasculature in diabetic retinopathy and the vascular origin of central serous chorio-retinopathy. He is also involved in a several prospective clinical trials on the use of anti-angiogenic therapy in AMD, retinal vein occlusion and diabetic retinopathy.
He undertook his residency in ophthalmology at the University of Amsterdam, The Netherlands, followed by a medical retina fellowship with Professor Alan Bird at Moorfields Eye Hospital, London. He is now Professor of Ophthalmology and Medical Retina Specialist at the Amsterdam UMC in Amsterdam, and Director of Research and Invited Professor at the Jules-Gonin Eye Hospital, University of Lausanne .
Professor Schlingemann’s research interests include: the role of growth factors in ocular angiogenesis and fibrosis-particularly in AMD and diabetic retinopathy; the cellular mechanisms underlying loss of the blood-retinal barrier in diabetic retinopathy; vaso-occlusive mechanisms that cause non-perfusion of the retinal vasculature in diabetic retinopathy and the vascular origin of central serous chorio-retinopathy. He is also involved in a several prospective clinical trials on the use of anti-angiogenic therapy in AMD, retinal vein occlusion and diabetic retinopathy.
Jerry Sebag
VMR Institute for Vitreous Macula Retina & Doheny Eye Institute/UCLA, USA
Biography
Jerry Sebag
VMR Institute for Vitreous Macula Retina & Doheny Eye Institute/UCLA, USA
Educated at the Bronx High School of Science, Columbia, and Harvard, Dr. Sebag was trained in vitreous by Endre Balazs and in retina by Charles Schepens. He is presently Senior Research Scientist at the Doheny Eye Institute in Pasadena and Professor of Clinical Ophthalmology at UCLA. As of 2024, he has authored 270 academic publications and delivered an equal number of lectures/abstracts on various aspects of vitreo-retinal health and disease. Dr. Sebag's Google Scholar H-index = 56, with 12,947 citations to his publications. His 2014 textbook on vitreous is a classic, with 186,000 downloads: https://link.springer.com/book/10.1007%2F978-1-4939-1086-1 (translated into Chinese in 2022).
A 1983-84 fellow of the John Simon Guggenheim Foundation and currently a fellow of the American College of Surgeons and the Royal College of Ophthalmologists (UK), Dr. Sebag has delivered 72 named and invited lectures throughout the world, including a keynote lecture to the Japanese Retina & Vitreous Society (1997), a guest lecture at the Cambridge Ophthalmological Symposium, Cambridge, England (2001), the Retinal Research Lecture, Macula Foundation, New York (2009), Plenary Lecture at the Joint meeting of Japanese Retina and Vitreous Society and the Asia Pacific Vitreo-Retinal Society (2013), the Inaugural Robert Machemer Keynote Lecture to the European Society of Ophthalmology (2019), and the Meyer-Schwickerath Lecture at the 35th International Congress of German Ophthalmic Surgery (2023).
A 1983-84 fellow of the John Simon Guggenheim Foundation and currently a fellow of the American College of Surgeons and the Royal College of Ophthalmologists (UK), Dr. Sebag has delivered 72 named and invited lectures throughout the world, including a keynote lecture to the Japanese Retina & Vitreous Society (1997), a guest lecture at the Cambridge Ophthalmological Symposium, Cambridge, England (2001), the Retinal Research Lecture, Macula Foundation, New York (2009), Plenary Lecture at the Joint meeting of Japanese Retina and Vitreous Society and the Asia Pacific Vitreo-Retinal Society (2013), the Inaugural Robert Machemer Keynote Lecture to the European Society of Ophthalmology (2019), and the Meyer-Schwickerath Lecture at the 35th International Congress of German Ophthalmic Surgery (2023).
Ashish Sharma
Consultant Retina and Head Research, Lotus Eye Hospital and Institute, India
Biography
Ashish Sharma
Consultant Retina and Head Research, Lotus Eye Hospital and Institute, India
Dr Ashish Sharma completed his clinical retina and research fellowship from the University of California Irvine, USA. Before Joining Lotus Eye Hospital, Coimbatore India, he served as a Clinical Instructor at the University of California Irvine, USA, and as faculty at LVPEI Hyderabad, India. His areas of interest are DME, ARMD, Ocular Pharmacotherapy, and recent imaging techniques. He holds the patent on the fundus imaging device MII Ret Cam and has 2 patent pending innovations. He has been awarded as International Ophthalmologist Education Award by the American Academy of Ophthalmology Board of Trustees and the Ophthalmic Hero of India by All India Ophthalmic Society. He has published 100 plus articles in indexed journals along with chapters. He is on the reviewing and editorial boards of high-impact ophthalmology journals. He has been listed in the Stanford top researchers list in Ophthalmology in India for the last 2 years.
Thanapong Somkijrungroj
Chulalongkorn University, Thailand
Biography
Thanapong Somkijrungroj
Chulalongkorn University, Thailand
Dr.Thanapong graduated from Phramongkutklao College of Medicine, Bangkok, Thailand in 2004 and did his residency training in Ophthalmology at Rajavithi Hospital, Bangkok, Thailand. He was a Chief of Uveitis unit at Chulalongkorn University and Hospital which he joined in June 2012. He did his retina fellowship training at Chulalongkorn University the same year he joined the faculty. Dr.Thanapong also did his overseas fellowship training in both Uveitis and Medical Cornea in 2014 at Francis I. Proctor Foundation, University of California, San Francisco. He is the founder of Chula-KKU-Proctor-UCSF (CKPU) meeting in January 2016. He has been involved as an instructor to train 2-3 retina fellows each year and recently opened a uveitis fellow training program at his university in 2017.
Dr.Thanapong’s research interests are imaging in uveitis/retina, diagnostic test for uveitis, CMV keratouveitis, Ocular Behcet and other Infectious uveitis. Dr.Thanapong is involved in many innovative projects including Intravitreal drug delivery device and ophthalmic anesthesia injection model. He also specializes in management of complicated cataracts and complex retina diseases related to intraocular inflammation.
In addition, Dr.Thanapong received “The Distinguished Service Award” from ACOM community in 2017 and the best paper of the Session award in the 34th APACRS in 2022. He is an active member of The Royal Colleague of Ophthalmology of Thailand (RCOPT), Thai Retina Society, Thailand Intraocular Inflammation, and Uveitis Society. Dr.Thanapong was recently elected President of Cataract and Refractive Surgery Society of Thailand in 2021 and participated as a speaker in many local and regional meetings.
Dr.Thanapong’s research interests are imaging in uveitis/retina, diagnostic test for uveitis, CMV keratouveitis, Ocular Behcet and other Infectious uveitis. Dr.Thanapong is involved in many innovative projects including Intravitreal drug delivery device and ophthalmic anesthesia injection model. He also specializes in management of complicated cataracts and complex retina diseases related to intraocular inflammation.
In addition, Dr.Thanapong received “The Distinguished Service Award” from ACOM community in 2017 and the best paper of the Session award in the 34th APACRS in 2022. He is an active member of The Royal Colleague of Ophthalmology of Thailand (RCOPT), Thai Retina Society, Thailand Intraocular Inflammation, and Uveitis Society. Dr.Thanapong was recently elected President of Cataract and Refractive Surgery Society of Thailand in 2021 and participated as a speaker in many local and regional meetings.
Chang-Hao Yang
National Taiwan University Hospital, Taiwan
Biography
Chang-Hao Yang
National Taiwan University Hospital, Taiwan
Dr. Yang is Professor of the Department of Ophthalmology, National Taiwan University. He graduated from School of Medicine, National Taiwan University and received his PhD from Institute of Clinical Medicine, School of Medicine, National Taiwan University. He did his residency training at Department of Ophthalmology, National Taiwan University Hospital and had research fellow training at Duke University Eye Center, USA. His clinical and research interests lie in the medical and surgical management of retinal diseases, particularly ocular angiogenesis and inflammation, choroidal neovascularization, polypoidal choroidal vasculopathy, diabetic retinopathy, stem cell research, and retinal prosthesis. As one of the leading experts in vitreoretinal diseases in the Asia-Pacific region, Dr. Yang has published more than 180 articles in international peer-reviewed indexed journals. He has also delivered invited lectures in the international ophthalmic meetings. Currently he is the President of Taiwan Academy of Ophthalmology.
Martin S Zinkernagel
University Hospital Bern, Switzerland
Biography
Martin S Zinkernagel
University Hospital Bern, Switzerland
Professor Martin S. Zinkernagel is Chair of the Department of Ophthalmology at the University Hospital of Bern, Switzerland and director of the internationally renowned Bern Photographic Reading Center at the University of Bern. He earned his M.D from the University of Zurich and a PhD in ocular immunology and gene therapy from the University of Western Australia. Main clinical interests encompass vitreoretinal surgery, medical retina, ocular traumatology and cataract surgery. His main research interests are retinal imaging, ophthalmic data analysis using artificial intelligence and the influence of the gut microbiome in retinal disease and. Basic science interests are ocular immunology and inflammation.
He currently serves as general secretary and member of the board of EURETINA, board member of EUEYE and is editor in chief of Ophthalmologica. He is member of various ophthalmology societies around the world.
He currently serves as general secretary and member of the board of EURETINA, board member of EUEYE and is editor in chief of Ophthalmologica. He is member of various ophthalmology societies around the world.